Data investigation

South Dakota Medicaid and Wegovy or Zepbound: No Weight-Loss Coverage, Three PA Routes

South Dakota Medicaid lists weight-loss drugs as not covered. Its 2026 OptumRx forms open three routes: Wegovy for heart disease, Wegovy for fatty liver disease with scarring, and Zepbound for sleep apnea. What each form asks, the diabetes split, timelines and appeals.

By Nora Bissett · Pricing Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
7 min read·13 citations

No. As of November 2026, South Dakota Medicaid does not pay for Wegovy, Zepbound or any drug used for weight loss; its pharmacy manual lists those agents as not covered.[1] The state’s prior authorization forms do open three narrower routes: Wegovy to lower heart risk or to treat the liver disease MASH in people without diabetes, and Zepbound for moderate to severe sleep apnea.[2][3]

About this article. This page reads South Dakota Medicaid’s Pharmacy Services manual (updated May 2026), the state’s Wegovy, Zepbound and GLP-1 request forms (April and May 2026 versions) and the state’s appeal rules, as they stood on November 7, 2026. We could not open the preferred drug list or the criteria pages on the state’s pharmacy website, which we could not open, so this page does not say which brand is preferred or what score cutoffs reviewers use. For every state side by side, use the state Medicaid GLP-1 checker.

Will South Dakota Medicaid pay for Wegovy or Zepbound to lose weight?

It does not. The Pharmacy Services manual has a list of items and services South Dakota Medicaid will not pay for, and one bullet on it reads “Agents used for anorexia, weight loss, weight gain, hair growth or cosmetic purposes.”[1] The Wegovy and Zepbound request forms repeat the point in a line under the diagnosis boxes: neither drug is covered “for obesity or weight management.”[2][3]

There is one oddity in the paperwork. The state’s administrative rule on drugs it does not cover names fertility, cosmetic and hair growth products but leaves weight loss off its list.[5] The manual and the forms are what the pharmacy system follows, though, and under federal law any state may drop weight-loss drugs from Medicaid.[1][9] Our explainer on how Medicaid handles Ozempic and Wegovy covers that federal option.

When will South Dakota Medicaid pay for a GLP-1?

In four situations, each requested on a separate OptumRx form. Optum processes South Dakota’s pharmacy claims and prior authorizations, while the state says it keeps sole control of the benefit itself.[1]

South Dakota Medicaid GLP-1 routes on the OptumRx request forms, April and May 2026 versions
UseDrugWhat the form asks for
Weight loss aloneWegovy, ZepboundNot covered; no route
Type 2 diabetesGLP-1 agonists (separate form)Type 2 diabetes diagnosis; quantity limits apply
Lowering heart attack and stroke riskWegovyNo diabetes; prior heart attack, stroke or peripheral artery disease; current lipid-lowering and antiplatelet drugs; tobacco status
MASH with F2 or F3 fibrosisWegovyNo diabetes; no decompensated cirrhosis; supervised weight plan; prescribed by or with a specialist
Moderate to severe sleep apneaZepboundSleep study result in events per hour; BMI; supervised weight plan; no DPP-4 drug or second GLP-1

The diabetes line matters more than it looks. Both Wegovy routes are labeled “without diabetes,” the Wegovy form asks for an HbA1c from the last two months, and the Wegovy and Zepbound forms both say the drug is not covered for type 2 diabetes.[2][3] A person who has diabetes is meant to use the separate GLP-1 agonist form, which has a single diagnosis box for type 2 diabetes.[4]

What does the Wegovy form require for heart disease?

The heart route tracks the Wegovy label, written for adults who already have heart or blood vessel disease and who also carry excess weight.[11] South Dakota’s form asks the prescriber to show one of three events or diagnoses, each with its ICD-10 code: a prior heart attack, a prior stroke, or peripheral arterial disease.[2] It then asks whether the patient takes lipid-lowering and antiplatelet drugs, whether the patient smokes, and if so whether tobacco counseling was given.[2]

The form asks for the BMI to one decimal place but does not print a cutoff.[2] Requests for Wegovy tablets carry one more question: has the patient had a 90-day trial of Rybelsus, the oral semaglutide sold for diabetes, that did not work?[2]

Will South Dakota Medicaid cover Wegovy for fatty liver disease?

Yes, for MASH with moderate to advanced scarring, and only through prior authorization. The form asks whether fibrosis is stage F2 or F3, the range the FDA approved on an accelerated basis.[2][11] It also asks whether the patient has decompensated cirrhosis, rated Child-Pugh class B or C, and whether the patient is in a supervised weight management plan.[2]

This is the only South Dakota route that names specialists. The prescriber marks whether Wegovy is prescribed by or with an endocrinologist, gastroenterologist or hepatologist, and an “other” box is offered.[2] Our page on GLP-1s for MASH explains the trial results behind the liver approval.

Does South Dakota Medicaid cover Zepbound for sleep apnea?

Yes, through the Zepbound for OSA form, dated May 2026.[3] The only diagnosis it offers is moderate to severe obstructive sleep apnea, which matches the label: adults with obesity.[3][10] The prescriber gives the BMI, confirms a sleep study, and writes down the number of breathing events per hour that study recorded.[3] The form also asks about a supervised weight plan, any DPP-4 diabetes drug or second GLP-1, and whether the patient or a close relative has had medullary thyroid cancer or MEN2.[3]

Two things are absent. The form prints no minimum AHI or BMI, and it has no question about trying CPAP first.[3] Reviewers may still apply criteria that sit on the state’s criteria pages, which we could not read. Our guide to Zepbound for sleep apnea covers the clinical side.

How long does a South Dakota prior authorization take?

Most requests are decided within 72 hours, and a complete one often in under a day, the manual says.[1] Approvals end on a set date, typically after a year, and are never backdated: a prescription filled before approval is the patient’s bill.[1] The prescriber faxes the form to Optum at 1-844-403-1029, and urgent requests go by phone to 1-855-401-4262.[2] That line asks for an NPI number, so patients cannot use it to ask why a drug was denied.[1]

How do you appeal a denial in South Dakota?

There are two tracks. The prescriber can appeal a prior authorization denial directly, but state rule gives only 24 hours from the denial to do so, with a decision due within 24 hours of the new information.[6] A denial based on missing paperwork, such as no sleep study result, is often fixed fastest this way. No appeal can help if the only diagnosis is obesity, since no route exists for that.[1]

The member’s own route is a fair hearing. For Medicaid, the request can be written or oral and goes to the hearings office of the state Department of Social Services.[8] It must be made within 30 days after the notice of the action.[7] Our walkthrough of prior authorization and appeals covers what belongs in the file, and the South Dakota state page has the same Medicaid facts in brief.

What are the options if South Dakota Medicaid will not pay?

Manufacturer copay cards are closed to Medicaid members: Lilly’s Zepbound card terms exclude anyone in a government-funded program, Medicaid included.[12] Self-pay is the fallback. In the figures we track, Novo Nordisk sells most Wegovy pen doses for $349 a month, and Lilly’s Zepbound runs $299 at the starting dose, $399 at 5 mg and $449 at higher doses when refilled on schedule.[12][13] Check each offer’s rules on government coverage before signing up. Our list of the lowest-cost ways to buy a GLP-1 without insurance compares them.

Frequently Asked Questions

Not for weight loss. As of November 2026 the state's pharmacy manual lists weight-loss drugs as not covered. Wegovy can be approved through prior authorization for two other uses in people without diabetes: cutting heart risk in someone with a past heart attack or stroke or with artery disease in the legs, and treating MASH with F2 or F3 liver fibrosis.
Yes, with prior authorization. The state's Zepbound form covers moderate to severe obstructive sleep apnea and asks for a sleep study result, the patient's BMI and enrollment in a supervised weight plan. It is not covered for weight management or type 2 diabetes.
Diabetes GLP-1 drugs are requested on a separate South Dakota form whose diagnosis box is type 2 diabetes. All drugs in the program may need prior authorization. Neither drug is covered for weight loss.
OptumRx processes claims and prior authorization requests, though the state says Optum is not its pharmacy benefit manager. Prescribers fax forms to 1-844-403-1029 or call 1-855-401-4262 for urgent requests. Most requests are decided within 72 hours.
A member asking for a fair hearing must do so within 30 days after the notice of the action, in writing or orally, to the Office of Administrative Hearings. A prescriber appealing a prior authorization denial directly has only 24 hours after the denial.

References

  1. 1.South Dakota Department of Social Services South Dakota Medicaid Billing and Policy Manual: Pharmacy Services, updated May 2026 dss.sd.gov. 2026. https://dss.sd.gov/docs/medicaid/providers/billingmanuals/Pharmacy/Pharmacy_Services.pdf
  2. 2.South Dakota Medicaid; OptumRx Wegovy Prior Authorization Request Form (South Dakota Medicaid, April 2026) contenthub-aem.optumrx.com. 2026. https://contenthub-aem.optumrx.com/content/dam/contenthub/retail-pharmacy-override/assets/customsite-southdokata/documents/Wegovy_SDM.pdf
  3. 3.South Dakota Medicaid; OptumRx Zepbound for OSA Prior Authorization Request Form (South Dakota Medicaid, May 2026) contenthub-aem.optumrx.com. 2026. https://contenthub-aem.optumrx.com/content/dam/contenthub/retail-pharmacy-override/assets/customsite-southdokata/documents/Zepbound_OSA_SDM.pdf
  4. 4.South Dakota Medicaid; OptumRx GLP-1 Agonists Prior Authorization Request Form (South Dakota Medicaid, May 2026) contenthub-aem.optumrx.com. 2026. https://contenthub-aem.optumrx.com/content/dam/contenthub/retail-pharmacy-override/assets/customsite-southdokata/documents/GLP1Agonists_SDM.pdf
  5. 5.State of South Dakota ARSD 67:16:14:05: Items and services not covered South Dakota Legislature. 2021. https://sdlegislature.gov/api/Rules/67:16:14:05.html
  6. 6.State of South Dakota ARSD 67:16:14:24: Appeal process (prior authorization) South Dakota Legislature. 2006. https://sdlegislature.gov/api/Rules/67:16:14:24.html
  7. 7.State of South Dakota ARSD 67:17:02:04: Time limits for requesting hearing South Dakota Legislature. 2025. https://sdlegislature.gov/api/Rules/67:17:02:04.html
  8. 8.State of South Dakota ARSD 67:17:02:03: Hearing requests South Dakota Legislature. 2025. https://sdlegislature.gov/api/Rules/67:17:02:03.html
  9. 9.United States Code 42 U.S.C. §1396r-8: Payment for covered outpatient drugs (Social Security Act §1927) Legal Information Institute, Cornell Law School. 2026. https://www.law.cornell.edu/uscode/text/42/1396r-8
  10. 10.Eli Lilly and Company ZEPBOUND (tirzepatide) injection: prescribing information DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  11. 11.Novo Nordisk WEGOVY (semaglutide) injection and tablets: prescribing information DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  12. 12.Eli Lilly and Company Zepbound savings and self-pay options, with card terms zepbound.lilly.com. 2026. https://zepbound.lilly.com/savings
  13. 13.Novo Nordisk Wegovy savings offer novocare.com. 2026. https://www.novocare.com/obesity/products/wegovy/savings-offer.html

Does Montana Medicaid Cover Wegovy or Zepbound? Heart, MASH and Sleep Apnea Rules

Montana Medicaid will not pay for any drug used for weight loss. Its PA forms still approve Wegovy for heart disease or MASH, plus Zepbound for sleep apnea that CPAP has not controlled. Criteria, specialists, renewals and the 90-day appeal window.

7 min read

Does New Hampshire Medicaid Still Cover Wegovy or Zepbound? The 2026 Rules

On January 1, 2026, New Hampshire Medicaid dropped GLP-1s prescribed only to lose weight. Prior authorization still opens Wegovy for heart disease or fatty liver and Zepbound for apnea, along with older weight-loss pills. The diet, CPAP and liver test rules, and appeals.

8 min read

Does NJ Medicaid Cover Zepbound or Wegovy? NJ FamilyCare's GLP-1 Rules

New Jersey's Medicaid rule bars obesity drugs, yet NJ FamilyCare pays for Zepbound when sleep apnea is diagnosed and for Wegovy in heart disease or MASH. The protocol criteria, the orlistat exception, what full coverage would cost the state, and how to appeal.

8 min read

Does Medi-Cal Cover Wegovy or Zepbound? Not for Adult Weight Loss Since January 2026

California's Medicaid program dropped GLP-1s for adult weight loss on January 1, 2026, at any BMI. Wegovy for MASH needs only a diagnosis code; heart and sleep apnea requests go through prior authorization. Under-21 reviews, hearing deadlines and cash options.

8 min read

Does North Dakota Medicaid Cover Wegovy? The Ozempic-First Routes Explained

North Dakota Medicaid will not pay for any GLP-1 to lose weight, yet its October 2026 drug list opens heart, MASH and sleep apnea routes with Ozempic as the preferred semaglutide. The age and BMI window, the CPAP rule, older obesity drugs and appeals.

8 min read

Does Illinois Medicaid Cover Ozempic, Wegovy or Zepbound? Diabetes Yes, Weight Loss No

Illinois Medicaid's October 2026 drug list covers Ozempic for type 2 diabetes, with the tablets preferred over the pen, and opens Wegovy for heart risk and MASH and Zepbound for sleep apnea. Weight loss alone stays excluded. Status by drug, plan criteria and appeals.

7 min read

Where to get tirzepatide online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.2

bmiMD

Starting below a standard dose, with microdose tiers

8.7

Eden

Coverage in all 50 states, which most sellers will not confirm

See the South Dakota page for the sellers that ship there and other facts about the state.

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →